312 related items for PubMed ID: 27105393
1. Hypertension in children with congenital adrenal hyperplasia.
Maccabee-Ryaboy N, Thomas W, Kyllo J, Lteif A, Petryk A, Gonzalez-Bolanos MT, Hindmarsh PC, Sarafoglou K.
Clin Endocrinol (Oxf); 2016 Oct; 85(4):528-34. PubMed ID: 27105393
[Abstract] [Full Text] [Related]
2. Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency.
Bonfig W, Roehl FW, Riedl S, Dörr HG, Bettendorf M, Brämswig J, Schönau E, Riepe F, Hauffa B, Holl RW, Mohnike K, AQUAPE CAH Study Group.
Am J Hypertens; 2016 Feb; 29(2):266-72. PubMed ID: 26071487
[Abstract] [Full Text] [Related]
3. Sodium Chloride Supplementation Is Not Routinely Performed in the Majority of German and Austrian Infants with Classic Salt-Wasting Congenital Adrenal Hyperplasia and Has No Effect on Linear Growth and Hydrocortisone or Fludrocortisone Dose.
Bonfig W, Roehl F, Riedl S, Brämswig J, Richter-Unruh A, Fricke-Otto S, Hübner A, Bettendorf M, Schönau E, Dörr H, Holl RW, Mohnike K.
Horm Res Paediatr; 2018 Feb; 89(1):7-12. PubMed ID: 29073619
[Abstract] [Full Text] [Related]
4. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
5. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
J Pediatr; 2015 Mar; 166(3):743-50. PubMed ID: 25557963
[Abstract] [Full Text] [Related]
6. Blood pressure, fludrocortisone dose and plasma renin activity in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency followed from birth to 4 years of age.
Bonfig W, Schwarz HP.
Clin Endocrinol (Oxf); 2014 Dec; 81(6):871-5. PubMed ID: 24818525
[Abstract] [Full Text] [Related]
7. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
Sarafoglou K, Lorentz CP, Otten N, Oetting WS, Grebe SK.
Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
[Abstract] [Full Text] [Related]
8. Obesity in children with congenital adrenal hyperplasia in the Minnesota cohort: importance of adjusting body mass index for height-age.
Sarafoglou K, Forlenza GP, Yaw Addo O, Kyllo J, Lteif A, Hindmarsh PC, Petryk A, Gonzalez-Bolanos MT, Miller BS, Thomas W.
Clin Endocrinol (Oxf); 2017 May; 86(5):708-716. PubMed ID: 28199739
[Abstract] [Full Text] [Related]
9. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report.
Roche EF, Charmandari E, Dattani MT, Hindmarsh PC.
Clin Endocrinol (Oxf); 2003 May; 58(5):589-96. PubMed ID: 12699440
[Abstract] [Full Text] [Related]
10. Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience.
Premawardhana LD, Hughes IA, Read GF, Scanlon MF.
Clin Endocrinol (Oxf); 1997 Mar; 46(3):327-32. PubMed ID: 9156043
[Abstract] [Full Text] [Related]
11. Profile of children with congenital adrenal hyperplasia--a hospital study.
Bhanji R, Khan AH, Balouch IL, Sabir S, Nazir Z, Billoo AG.
J Pak Med Assoc; 2004 Oct; 54(10):509-12. PubMed ID: 15552284
[Abstract] [Full Text] [Related]
12. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltrão LA, Spritzer PM.
BMC Pediatr; 2017 Jan 17; 17(1):22. PubMed ID: 28095810
[Abstract] [Full Text] [Related]
13. Blood pressure in the first year of life in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a pilot study.
Mooij CF, Kapusta L, Otten BJ, Claahsen-van der Grinten HL.
Horm Res Paediatr; 2010 Jan 17; 74(5):328-32. PubMed ID: 20357427
[Abstract] [Full Text] [Related]
14. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
Santos CM, Abad LR, Cua SC, Domingo CF.
Southeast Asian J Trop Med Public Health; 2003 Jan 17; 34 Suppl 3():174-8. PubMed ID: 15906729
[Abstract] [Full Text] [Related]
15. Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary.
Török D, Eckhardt G, Sólyom J.
Eur J Pediatr; 2003 Dec 17; 162(12):844-9. PubMed ID: 14648216
[Abstract] [Full Text] [Related]
16. Long-term Growth in Congenital Adrenal Hyperplasia.
Maheshwari A, Khadilkar V, Gangodkar P, Khadilkar A.
Indian J Pediatr; 2019 Feb 17; 86(2):154-158. PubMed ID: 30097840
[Abstract] [Full Text] [Related]
17. Congenital adrenal hyperplasia: issues in diagnosis and treatment in children.
Sharma R, Seth A.
Indian J Pediatr; 2014 Feb 17; 81(2):178-85. PubMed ID: 24254335
[Abstract] [Full Text] [Related]
18. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
Votava F, Török D, Kovács J, Möslinger D, Baumgartner-Parzer SM, Sólyom J, Pribilincová Z, Battelino T, Lebl J, Frisch H, Waldhauser F, Middle European Society for Paediatric Endocrinology -- Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group.
Eur J Endocrinol; 2005 Jun 17; 152(6):869-74. PubMed ID: 15941926
[Abstract] [Full Text] [Related]
19. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C.
Clin Endocrinol (Oxf); 2002 Nov 17; 57(5):669-76. PubMed ID: 12390343
[Abstract] [Full Text] [Related]
20. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
Hird BE, Tetlow L, Tobi S, Patel L, Clayton PE.
Arch Dis Child; 2014 Feb 17; 99(2):158-64. PubMed ID: 24225272
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
